The elusive pursuit of progress in limited stage small-cell lung cancer

Affiliations

¹ Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit, 1007 MB Amsterdam, Netherlands. Electronic address: s.senan@amsterdamumc.nl.

Comment

Suresh Senan. Lancet Oncol. 2021 Mar.

. 2021 Mar;22(3):290-291.

doi: 10.1016/S1470-2045(21)00018-8.

¹ Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit, 1007 MB Amsterdam, Netherlands. Electronic address: s.senan@amsterdamumc.nl.

No abstract available

Comment on

High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial.
Grønberg BH, Killingberg KT, Fløtten Ø, Brustugun OT, Hornslien K, Madebo T, Langer SW, Schytte T, Nyman J, Risum S, Tsakonas G, Engleson J, Halvorsen TO. Grønberg BH, et al. Lancet Oncol. 2021 Mar;22(3):321-331. doi: 10.1016/S1470-2045(20)30742-7. Lancet Oncol. 2021. PMID: 33662285 Clinical Trial.